Breast Cancer Coverage from Every Angle

Ongoing CE Activities

Advancing Shared Decision-Making and Patient-Centered Treatment in the Management of HER2-Negative and Triple Negative Breast Cancer
Applying Evidence-Based Clinical Decision-Making to Real-world Patient Cases to Support Safe, Effective, and Adherent Treatment in TNBC
Breast Cancer Prevention, Screening, Diagnosis, and Treatment
Breast Cancer Update, Issue 3, 2019: ER-Positive Edition
Breast Cancer Update: Triple-Negative Edition
CDK4/6 Inhibitors in HR+/HER2- Metastatic Breast Cancer: What We Have Learned From Real-World Evidence
Data + Perspectives: Clinical Investigators Explore the Current and Future Management of Triple-Negative Breast Cancer
Differentiating Established and Novel Treatment Approaches for TNBC Based on Mechanism of Action, Safety, Efficacy, and Approved Indications
Interactive Tumor Panel: Clinical Investigators Discuss Emerging Research and Actual Cases of Patients with Breast Cancer
Living with HR+/HER2- Breast Cancer: A Point-of-Care Oral Oncolytic Discussion Guide and Toolkit for Patients
Meet The Professor: Optimizing the Management of HER2-Positive Breast Cancer
Metastatic Disease Considerations in HR-Positive Breast Cancer
NCCN Guidelines Update: Treatment of Hormone-Sensitive Advanced Breast Cancer
Oncology Today with Dr Neil Love: Special Edition — Management of ER-Positive Breast Cancer
Oral Selective Estrogen Degraders: A Renewed Approach to Advanced Care for Hormone Receptor-Positive Breast Cancer
Proceedings from the First Annual Oncology Nursing Retreat ER-Positive Metastatic Breast Cancer
Proceedings from the First Annual Oncology Nursing Retreat HER2-Positive and Triple-Negative BC
The Role of Lifestyle and the Environment in Breast Cancer Risk
Transforming HR+/HER2- Breast Cancer Care: Real-world Patient and Provider Perspectives
Transforming Patient-Centered Care for HR+/HER2- Breast Cancer Patients Through Collaborative Learning: A Toolkit for Clinical Teams
Vision for treating and curing HER2-positive metastatic breast cancer (mBC) in the future
What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of ER-Positive Breast Cancer
When Should Women With a Family History of Breast Cancer Start Screening?
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Breast Cancer

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.